<?xml version="1.0" encoding="UTF-8"?>
<p id="p0435">Teicoplanin 
 <bold>(31)</bold> (
 <xref rid="f0025" ref-type="fig">Fig. 5</xref>) is an antibiotic used against gram-positive bacteria with 5 major compounds at different side chains. It prevents polymerization of peptidoglycans and inhibits the development of the cell-wall, thus prompting cell death.
 <xref rid="b1010" ref-type="bibr">
  <sup>202</sup>
 </xref> It is a big molecule that has displayed antiviral activity on an early stage of the viral life cycle by inhibiting the low-pH cleavage of the viral spike protein by cathepsin L in the late endosomes thereby preventing release of viral RNA and replication. This compound has already shown inhibitory activity against Ebola virus, MERS-CoV and SARS-CoV.
 <xref rid="b1010" ref-type="bibr">
  <sup>202</sup>
 </xref>
</p>
